News
-
Researching Research - A week of work experience at Bio21Kevin Cheung and Zara Tse report on a week of work experience at Bio21 Institute, 27th June - 1st July 2016.
-
How energy is hidden in coloursBy Errol Hunt, University of Melbourne
‘Roses are red and violets are blue’ – so says the old poem.
But why are roses red? And why are violets blue? What is it that gives something its colour?
-
Insectary opened at Bio21 to step up fight against dengueResearchers can now safely import, house and study mosquitoes from outside Australia, giving dengue research in Melbourne a significant boost.
-
Media Release: Legions of immune cells in the lung keep Legionella at bayA team of specialist researchers in Melbourne believe they have found a major response that helps keep the Legionella infection at bay.
-
Media Release: New molecular design to get hydrogen-powered cars motoringProfessor O’Hair, from the University’s School of Chemistry and Bio21 Institute's study has been published in Nature Communications today.
-
Professor Ary Hoffmann elected to the American Academy of Arts and SciencesProfessor Ary Hoffmann from the School of BioSciences and Bio21 Institute at the University of Melbourne has been elected into the American Academy of Arts and Sciences as a Foreign Honorary Member — Evolutionary and Population Biology, and Ecology.
-
Women in research rewarded for taking a riskAssociate Professor Uta Wille, Professor Leann Tilley, Dr Diana Stojanovski and Dr Kathryn Tiedje
By Florienne Loder
-
Move it or lose it: exploiting genetic diversity to fight extinctionBy Dr Ben Phillips, Dr Andrew Weeks and Professor Ary Hoffmann, School of Biosciences, University of Melbourne.
-
Media Release: CSL Announces $25 million Centenary Fellowship ProgramCSL’s Chief Executive Officer, Mr Paul Perreault, at the CSL Centenary Celebration Gala announcing the establishment of a new flagship $25 million fellowship program for early stage and translational research in Australia
-
SARTATE trial results to be presented at the upcoming 2016 SNMMI MeetingClarity’s strong collaboration with Associate Professor Paul Donnelly at the School of Chemistry and Bio21 Institute, University of Melbourne enabled the initial manufacture and development of the product that was then translated into the clinic in the recently completed SARTATE™ proof-of-concept clinical trial for neuroendocrine tumours (NETs).
